Imbrium Therapeutics Announces U.S. FDA Orphan Drug Designation for Tinostamustine for the Treatment of T-cell Prolymphocytic Leukemia - Argus Press https://t.co/fxSZBRXyqo
— IDRO (@IDROOhio) March 28, 2019
from Twitter https://twitter.com/IDROOhio
March 28, 2019 at 07:42AM
No comments:
Post a Comment